Mazor Robotics Ltd. (TASE: MZOR), a developer of innovative surgical
robots and complementary products, today announced the successful
completion of the first robot-guided brain surgical procedures, which
were performed with Mazor Robotics' technology. Neurosurgeons Dr. In-Se
Kim and Prof. Robert Schönmayr performed the first three cases at HSK
Hospital, (Horst Schmidt Kliniken GmbH) in Wiesbaden, Germany.
"As one of the first medical centers globally to adopt robotic
technology for spine surgeries, we are very proud to also be the first
to expand its use to brain surgeries," said Prof. Schönmayr.
"We see great potential in the application of robotic technology to
brain and spine surgeries. Our patients have been the best testament to
its clinical success," added Dr. Kim.
In addition to its proven applications in spine surgeries, Mazor
Robotics' technology is applicable in the brain for biopsies, shunt
placements and neurostimulation electrode placement such as for deep
brain stimulation (DBS). As a frameless treatment solution for brain
procedures, the robot's precision, simplicity and safety profile have
the potential to increase patient comfort, improve surgical accuracy and
provide a less invasive approach, as well as potentially increase
utilization of the installed base.
There are about 25,000 brain biopsies in the United States each year.
The DBS placement market is estimated to be several hundred million
dollars annually.
"While our core is spine surgery, we are thrilled that our technology
can be expanded to improve other surgical procedures," said Ori Hadomi,
CEO of Mazor Robotics. "Brain surgeries represent a large market
opportunity that is aligned with our current focus on spine.
Approximately half of surgeons who currently use Mazor's Renaissance and
SpineAssist robots for spinal surgeries are neurosurgeons, the call
point for brain surgery. By offering a spine surgery and brain surgery
solution, we provide a solution for a greater number of physicians in
the typical neurosurgery department."
Regulatory clearance for the brain application is pending in the U.S.
and Europe. Upon regulatory clearance, the brain application will be
available as an add-on to Mazor's Renaissance system at a separate price
point expected early 2013.